Larvol Delta - BenevolentAI-Announces-TopLine-Phase-IIa-Results-for-Its-Topical-panTrk-Inhibitor-BEN2293-1-in-MildtoModerate-Atopic-Dermatitis

BEN-2293 - BenevolentAI

https://www.businesswire.com/news/home/20230404006090/en/BenevolentAI-Announces-Top-Line-Phase-IIa-Results-for-Its-Topical-pan-Trk-Inhibitor-BEN-2293-1-in-Mild-to-Moderate-Atopic-Dermatitis

Apr 5, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next